2009
DOI: 10.1007/s00277-009-0810-y
|View full text |Cite
|
Sign up to set email alerts
|

Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 9 publications
1
0
0
Order By: Relevance
“…Whereas a thalidomide‐induced rash is observed in 20–25% of patients receiving the drug, TEN has been reported only rarely. Previous reports of thalidomide‐induced TEN include one patient with glioblastoma and two cases of multiple myeloma . As in our case, these patients were also receiving dexamethasone.…”
Section: Acknowledgmentssupporting
confidence: 64%
“…Whereas a thalidomide‐induced rash is observed in 20–25% of patients receiving the drug, TEN has been reported only rarely. Previous reports of thalidomide‐induced TEN include one patient with glioblastoma and two cases of multiple myeloma . As in our case, these patients were also receiving dexamethasone.…”
Section: Acknowledgmentssupporting
confidence: 64%